Low-dose rituximab in ITP: One and Done.
Sign Up to like & getrecommendations! Published in 2022 at "American journal of hematology"
DOI: 10.1002/ajh.26489
Abstract: Rituximab is a widely-used medication for many years, important in management of immune thrombocytopenia (ITP); however, the optimal rituximab dose remains unknown. Ni and colleagues report a clinical trial comparing 2 doses of rituximab: a… read more here.
Keywords: dose rituximab; dose; itp one; rituximab itp ... See more keywords
Long-Term Outcome of ABO-Incompatible Kidney Transplantation in Patients Treated With Low-Dose Rituximab Regimen.
Sign Up to like & getrecommendations! Published in 2020 at "Transplantation proceedings"
DOI: 10.1016/j.transproceed.2020.10.023
Abstract: BACKGROUND Introduction of rituximab in the desensitization protocols for ABO-incompatible (ABOI) kidney transplantation (KTX) has afforded excellent results. However, the acceptability of minimal dosage of rituximab in these protocols remains to be defined. METHODS Sixty-three… read more here.
Keywords: dose rituximab; low dose; group; transplantation ... See more keywords
Immunogenicity and safety of two doses of SARS‐CoV‐2 mRNA vaccine in kidney transplant recipients with low‐dose rituximab
Sign Up to like & getrecommendations! Published in 2022 at "International Journal of Urology"
DOI: 10.1111/iju.14978
Abstract: We evaluated whether the treatment history of low‐dose rituximab affected safety profiles, and humoral and cellular responses induced by severe acute respiratory syndrome coronavirus 2 messenger ribonucleic acid vaccine in healthy controls and kidney transplant… read more here.
Keywords: safety; dose rituximab; kidney transplant; transplant recipients ... See more keywords
Modified conditioning regimen with chidamide and high-dose rituximab for triple-hit lymphoma.
Sign Up to like & getrecommendations! Published in 2021 at "Journal of cellular and molecular medicine"
DOI: 10.1111/jcmm.16999
Abstract: Triple-hit lymphoma (THL), which is classified into high-grade B-cell lymphoma with rearrangements of MYC, BCL2 and BCL6, presents aggressive biological behaviour. High-dose chemotherapy followed by autologous hematopoietic stem cell transplantation (auto-HSCT) is considered to be… read more here.
Keywords: triple hit; dose rituximab; high dose; hit lymphoma ... See more keywords
Repeated low-dose rituximab treatment based on the assessment of circulating B cells in patients with refractory myasthenia gravis
Sign Up to like & getrecommendations! Published in 2019 at "Therapeutic Advances in Neurological Disorders"
DOI: 10.1177/1756286419871187
Abstract: Background: The objective of this study was to evaluate the efficacy and safety of repeated low-dose rituximab treatment guided by monitoring circulating CD19+ B cells in patients with refractory myasthenia gravis (MG). Methods: Patients with… read more here.
Keywords: rituximab; dose rituximab; low dose; treatment ... See more keywords
All-trans retinoic acid plus low-dose rituximab vs low-dose rituximab in corticosteroid-resistant or relapsed ITP.
Sign Up to like & getrecommendations! Published in 2021 at "Blood"
DOI: 10.1182/blood.2021013393
Abstract: The study aimed to compare the efficacy and safety of all-trans retinoic acid (ATRA) plus low-dose rituximab (LD-RTX) with LD-RTX monotherapy in corticosteroid-resistant or relapsed immune thrombocytopenia (ITP) patients. Recruited patients were randomized at a… read more here.
Keywords: dose rituximab; low dose; resistant relapsed; group ... See more keywords
Effect of low-dose rituximab treatment on autoimmune nodopathy with anti-contactin 1 antibody
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.939062
Abstract: Background Autoimmune nodopathy with anti-contactin-1 (CNTN1) responds well to rituximab instead of traditional therapies. Although a low-dose rituximab regimen was administered to patients with other autoimmune diseases, such as myasthenia gravis and neuromyelitis optica spectrum… read more here.
Keywords: anti cntn1; dose rituximab; rituximab treatment; low dose ... See more keywords